The local anaesthetic lidocaine protects the myocardium in ischaemia-reperf
usion situations. It is not known if this is the consequence of an anti-isc
haemic effect or an effect on reperfusion injury. Therefore, we investigate
d the effect of two concentrations of lidocaine on myocardial ischaemia-rep
erfusion injury and on reperfusion injury alone. We used an isolated rat he
art model where heart rate, ventricular volume and coronary flow were kept
constant. Hearts underwent 45 min of low-flow ischaemia followed by 90 min
reperfusion. Two groups received lidocaine 1.7 or 17 mug ml(-1) starting 5
min before the onset of reperfusion. In two additional groups, lidocaine in
fusion started 5 min before low-flow ischaemia. In all groups, lidocaine ad
ministration was stopped after 15 min of reperfusion. One group served as a
n untreated control (n=11 in each group). Left ventricular developed pressu
re (LVDP) and total creatine kinase release (CKR) were measured. Lidocaine
administration during ischaemia and reperfusion led to an improved recovery
of LVDP during reperfusion (1.7 mug ml(-1), 54 (SEM 10) mm Hg; 17 mug ml(-
1). 71 (9) mm Hg at 30 min of reperfusion; both significantly different fro
m control (21 (4) mm Hg) (P<0.05)) and a reduced CKR(1.7 <mu>g ml(-1), 79 (
13) IU; 17 mug ml(-1), 52 (8) IU at 30 min of reperfusion; both significant
ly different from control (130 (8) IU (P <0.05)). Lidocaine given during ea
rly reperfusion only, affected neither LVDP during reperfusion (1.7 mug ml(
-1), 19 (6) mm Hg (P= 1.0); 17 mug ml(-1), 36 (8) mm Hg (P=0.46)) nor CKR(1
56 (21) IU (P=0.50) and 106 (14) IU (P=0.57)). We conclude that lidocaine p
rotects the myocardium against ischaemic but not against reperfusion injury
in the isolated rat heart.